Returning for a second year the Synthetic Biology-Based Therapies Summit is the leading industry-defining forum made exclusively for leaders in the synthetic and engineered biology space, focusing on the technical challenges that lie ahead in the path towards commercialization.

Download the event guide to find out more

Learn from industry trailblazers at Arsenal Biosciences, bit.bio, Moderna, MIT, Novome Bio, Strand Therapeutics, Synlogic and more, to support your efforts in developing safe and effective synthetic biology-based therapeutics.

Join Global Innovators to:

• Learn from the academics that are driving the future of synthetic biology development with the National Institute of Standards & Technology and Massachusetts Institute of Technology
• Leverage novel control strategies for improved therapeutic efficacy and patient safety with Arsenal Biosciences, bit.bio, CHAIN Biotechnology and Strand Therapeutics
• Employ synthetic biology techniques in the clinic, hearing about a variety of therapeutic applications with Kite Pharma: A Gilead Company, Novome Biotechnologies and Senti Biosciences
• Apply computation, artificial intelligence, and machine learning to engineered and synthetic biology with Lawrence Berkley National Laboratory and Sanofi
• Explore the potential for engineered biology as a tool for drug discovery and development with LifeMine Therapeutics and Merck & Co.